| scholarly article | Q13442814 |
| P50 | author | Matthew R. Reynolds | Q71301800 |
| P2093 | author name string | Mark E Josephson | |
| Alfred E Buxton | |||
| Brian Olshansky | |||
| Peter Zimetbaum | |||
| Vidal Essebag | |||
| Robert Lemery | |||
| Tom Hadjis | |||
| P2860 | cites work | Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure | Q24799850 |
| Gender differences in the electrophysiological characteristics of atrioventricular conduction system and their clinical implications | Q33147190 | ||
| Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions. | Q33152473 | ||
| Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs | Q33174249 | ||
| Time-dependent covariates in the Cox proportional-hazards regression model | Q33649238 | ||
| Evidence-based analysis of amiodarone efficacy and safety | Q33771489 | ||
| Gender-related differences in pharmacokinetics and their clinical significance | Q33785861 | ||
| A comparison of rate control and rhythm control in patients with atrial fibrillation | Q34162727 | ||
| Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial | Q34512370 | ||
| Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study | Q34533998 | ||
| Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase. | Q34541206 | ||
| Amiodarone versus sotalol for atrial fibrillation | Q34557369 | ||
| How important are gender differences in pharmacokinetics? | Q34660699 | ||
| Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues | Q35096853 | ||
| Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis | Q35107044 | ||
| Sex differences in pharmacokinetics and pharmacodynamics | Q35639177 | ||
| Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study. | Q35677114 | ||
| Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine | Q35825448 | ||
| Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. | Q36015557 | ||
| Cellular electropharmacology of amiodarone | Q40888033 | ||
| Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital | Q41572384 | ||
| Is rate control or rhythm control preferable in patients with atrial fibrillation? An argument for maintenance of sinus rhythm in patients with atrial fibrillation | Q44254820 | ||
| Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction | Q44283425 | ||
| Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug | Q44505465 | ||
| Use of population modeling to define rational monitoring of amiodarone hepatic effects | Q44827298 | ||
| Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study | Q45012571 | ||
| Sex-related differences in the pharmacokinetics of isosorbide-5-mononitrate (60 mg) after repeated oral administration of two different original prolonged release formulations. | Q45058131 | ||
| Effect of amiodarone dose on the risk of permanent pacemaker insertion | Q45152243 | ||
| Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability | Q47725181 | ||
| Gender differences in adverse drug reactions. | Q50856409 | ||
| Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. | Q51031228 | ||
| Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France. | Q51684458 | ||
| Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. | Q52131483 | ||
| Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment | Q68386738 | ||
| Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects | Q69106080 | ||
| Plasma concentration time course and pharmacological effects of a standardized oral amiodarone dosing regimen in humans | Q70176687 | ||
| Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil | Q73028182 | ||
| Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators | Q73594702 | ||
| Adverse effects of low dose amiodarone: a meta-analysis | Q73665648 | ||
| Gender-based differences in the toxicity of pharmaceuticals--the Food and Drug Administration's perspective | Q74318031 | ||
| A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation | Q78613787 | ||
| Is there a role for maintaining sinus rhythm in patients with atrial fibrillation? | Q80946434 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atrial fibrillation | Q815819 |
| amiodarone | Q410061 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1648-1653 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation | |
| P478 | volume | 167 |
| Q52685539 | Cardiac implantable electrical devices in women. |
| Q36335289 | Gender-based personalized pharmacotherapy: a systematic review |
| Q38508942 | Impact of sex and ethnicity on arrhythmic risk |
| Q34801922 | Sex-Based Differences in Cardiac Arrhythmias, ICD Utilisation and Cardiac Resynchronisation Therapy |
| Q35568937 | The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada |
Search more.